Document is current

Any future updates will be listed below

Preclinical exploration of combined glucagon inhibition and liver-preferential insulin for treatment of diabetes using in vitro assays and rat and mouse models

Crossref DOI link: https://doi.org/10.1007/s00125-022-05828-w

Published Online: 2022-11-21

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark